Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation

Pediatr Blood Cancer. 2008 Feb;50(2):415-8. doi: 10.1002/pbc.21072.

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is the most common treatment related malignancy that occurs after solid organ transplantation (SOT). PTLD has extended from its initial description as an Epstein-Barr virus (EBV)-driven B-cell proliferation to include EBV-negative and non B-lineage cases. T-cell PTLD (T-PTLD) is rare in both adults and children. We report two cases of pediatric T-PTLD after SOT (liver and lungs) and review cases reported in the literature. Both patients had a bimodal response to therapy with initial eradication of bulky nodal disease with regimens typically used to treat leukemia, but persistence of low-level clonal T-cells in marrow, CSF and lung in one case.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Liver Transplantation / adverse effects*
  • Lung Transplantation / adverse effects*
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / pathology*
  • T-Lymphocytes / pathology*